Bayer Trial Program Offers Six Free Infusions Of Kogenate FS
This article was originally published in The Pink Sheet Daily
Executive Summary
“The Kogenate FS Experience Program” includes an opportunity for hemophilia A patients in the U.S. to sample support programs and services, in addition to free treatment.
|
Bayer is launching a free product trial of Kogenate FS to provide hemophilia A patients in the U.S. an opportunity to receive six infusions, or up to 20,000 IU, of the recombinant Factor VIII delivered to their home. Marketed as "The Kogenate FS Experience Program," the trial offers patients free treatment with Kogenate FS, as well as an opportunity to sample the support programs and services that come with the therapy, Bayer said. The German company's biological products division announced the launch of the program Aug. 15. In addition to the free product, the trial package includes a free Kogenate FS "EZ-Log" electronic patient diary and an "Experience Kit," which outlines the services and support programs available with treatment, such as a peer-to-peer counseling program for families dealing with hemophilia. Patients who are interested in enrolling in the free trial are directed to download an enrollment form online or call a toll free number to request one. Patients who are currently being treated with Kogenate FS or are covered by federal or state healthcare programs are not eligible for the program, Bayer said. Second quarter sales of Kogenate FS advanced 28.9% to €39 mil. ($48.2 mil.), the firm said in an Aug. 10 interim report. Bayer attributed the steady growth to strong sales in Europe, where the brand continues to gain market share. Bayer retained rights to Kogenate FS last year while opting to divest its plasma products business to NPS BioTherapeutics (1 (Also see "Bayer To Retain Kogenate Line Following Plasma Unit Spin-Off" - Pink Sheet, 13 Dec, 2004.)). - Jessica Merrill |